opioid

Kapoor was sentenced to 5.5 years in prison for encouraging doctors to prescribe his drug "off-label" for ordinary chronic pain, while the drug was approved only for advanced cancer patients. An AARP review of FDA documents found that more than 8,100 people have died since 2012 while taking Subsys.

US Customs and Border Patrol stopped a tractor-trailer truck containing 254 pounds of Fentanyl, enough to kill 57 million people, crossing the US-Mexico border at the port of entry into the US. A dose of only two milligrams is enough to kill a person. In addition, the truck also contained 395 pounds of methamphetamine.

If the devil wears Prada, what do America’s most destructive drug pushers wear? They wear smiles. The drug pushers we have in mind here have caused hundreds of thousands of deaths, enough fatalities to decrease overall U.S. life expectancy at birth for the last two years running.


A new phenomenon has emerged in the United States: 64,000 people died in 2016 of a drug overdose—with 80% from opioids—with levels of addiction nearly 500% higher over the last six years.
Behind this epidemic is a multi-billion dollar industry, that feeds drug manufacturing giants, distributors and more.

Since the year 2000 at least 22 pharmaceutical companies have settled criminal and civil suits for over $10 billion in fines. Companies have been found guilty of fraud, kickbacks, false claims, and off label promotion. For example, In May 2007 Perdue Pharmaceuticals, makers of the opioid Oxycontin, was found guilty of “off label promotion” and paid over $600 million in fines, one of the largest in history. This occurred during the acceleration of the opioid epidemic according to the Center for Disease Control.

For years, illicit opiate use has been on the rise in the United States, leading to the worst drug crisis in U.S. history, one that has claimed ten times more lives in a single year than all terrorist attacks (including 9/11) on U.S. soil over the last two decades.

On June 8, 2017, the FDA requested that the drug-maker Endo Pharmaceuticals stop selling Opana ER – the extended-release version of Opana – because of “public health consequences of abuse.” It is the first time the agency has made efforts to pull an opioid from the market due to its highly addictive nature. [1]
According to the FBI, Opana ER is becoming a popular drug to crush, dissolve, and inject. An outbreak of HIV, Hepatitis C, and a serious blood disorder have been fueled by drug users sharing needles.

Drugs from a Pharmacy Health Shop (Photo via epSos .de/flickr)

(ANTIMEDIA) — Data compiled by the New York Times has shown that the number of drug overdose deaths in 2016 exceeded the 59,000 mark.

Ohio Attorney General Mike DeWine speaks during a news conference at a Kroger store to announce the chain’s decision to offer the opioid overdose reversal medicine Naloxone without a prescription, Feb. 12, 2016, in Cincinnati. (AP/John Minchillo)
Ohio Attorney General Mike DeWine announced Wednesday the filing of a lawsuit against numerous prescription pain medication manufacturers, as part of the Buckeye State’s ongoing effort to fight its opioid addiction epidemic.